D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.27B |
| 2 |
Meta Platforms (Facebook)
META
|
+$728M |
| 3 |
Microsoft
MSFT
|
+$524M |
| 4 |
T-Mobile US
TMUS
|
+$411M |
| 5 |
Uber
UBER
|
+$406M |
Top Sells
| 1 |
Visa
V
|
+$567M |
| 2 |
Charles Schwab
SCHW
|
+$531M |
| 3 |
Apple
AAPL
|
+$484M |
| 4 |
Johnson & Johnson
JNJ
|
+$455M |
| 5 |
Accenture
ACN
|
+$401M |
Sector Composition
| 1 | Technology | 25.5% |
| 2 | Consumer Discretionary | 13.42% |
| 3 | Healthcare | 12.98% |
| 4 | Financials | 9.15% |
| 5 | Industrials | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Victory Capital Holdings
VCTR
$4.64B
| $311K | ﹤0.01% |
9,861
-11,400
| -54% | -$360K |
|
2352
Merchants Bancorp
MBIN
$1.49B
| $308K | ﹤0.01% |
12,039
-23,102
| -66% | -$591K |
|
2353
Informatica
INFA
$7.55B
| $307K | ﹤0.01% |
16,586
-73,187
| -82% | -$1.35M |
|
2354
Ingles Markets
IMKTA
$1.32B
| $305K | ﹤0.01% |
3,696
-7,294
| -66% | -$603K |
|
|
TPC
2355
Tutor Perini Corporation
TPC
$3.34B
| $305K | ﹤0.01% |
42,648
+25,812
| +153% | +$185K |
|
|
ELME
2356
Elme Communities
ELME
$1.51B
| $305K | ﹤0.01% |
18,542
-22,427
| -55% | -$369K |
|
2357
Kearny Financial
KRNY
$415M
| $305K | ﹤0.01% |
43,218
-2,140
| -5% | -$15.1K |
|
2358
NewMarket
NEU
$7.95B
| $304K | ﹤0.01% |
757
+105
| +16% | +$42.2K |
|
2359
Udemy
UDMY
$1.08B
| $303K | ﹤0.01% |
28,242
-81,752
| -74% | -$877K |
|
2360
Aclaris Therapeutics
ACRS
$214M
| $300K | ﹤0.01% |
+28,923
| New | +$300K |
|
2361
First Advantage
FA
$2.76B
| $300K | ﹤0.01% |
19,438
-1,842
| -9% | -$28.4K |
|
2362
City Holding Co
CHCO
$1.83B
| $299K | ﹤0.01% |
3,320
-2,968
| -47% | -$267K |
|
2363
Chemours
CC
$2.51B
| $295K | ﹤0.01% |
8,000
-10,959
| -58% | -$404K |
|
|
STKL
2364
SunOpta
STKL
$739M
| $293K | ﹤0.01% |
43,850
-36,150
| -45% | -$242K |
|
|
RAD
2365
DELISTED
Rite Aid Corporation
RAD
| $293K | ﹤0.01% |
193,885
-104,684
| -35% | -$158K |
|
2366
Sensus Healthcare
SRTS
$52.8M
| $292K | ﹤0.01% |
92,776
-19
| -0% | -$60 |
|
2367
Acumen Pharmaceuticals
ABOS
$81.2M
| $291K | ﹤0.01% |
60,504
-99,704
| -62% | -$480K |
|
|
RPT
2368
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $290K | ﹤0.01% |
27,771
-34,147
| -55% | -$357K |
|
2369
Alpha and Omega Semiconductor
AOSL
$861M
| $289K | ﹤0.01% |
8,821
+214
| +2% | +$7.02K |
|
2370
S&P Global
SPGI
$167B
| $288K | ﹤0.01% |
+719
| New | +$288K |
|
2371
Darling Ingredients
DAR
$5.01B
| $286K | ﹤0.01% |
4,491
-2,759
| -38% | -$176K |
|
2372
Carlisle Companies
CSL
$16.1B
| $286K | ﹤0.01% |
1,116
-9,845
| -90% | -$2.53M |
|
|
AVPTW
2373
DELISTED
AvePoint Inc Warrant
AVPTW
| $284K | ﹤0.01% |
330,794
| – | – |
|
2374
Lindblad Expeditions
LIND
$742M
| $284K | ﹤0.01% |
+26,073
| New | +$284K |
|
2375
Ambarella
AMBA
$3.45B
| $283K | ﹤0.01% |
+3,385
| New | +$283K |
|